Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Baldwin

Showing results (721-730 of 961) with videos related to

Pageof 97
Sort By:
Bioconjugate Chemistry|January 17, 2002
Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporterRichard R Cesati, Gilles Tamagnan, Ronald M Baldwin, et al.
Transplantation|July 31, 2001
Coagulation markers predicting cardiac transplant rejectionJ B Segal, E K Kasper, C Rohde, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administrationAkira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Transplantation|March 27, 1997
Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenograftsS K Pruitt, R R Bollinger, B H Collins, et al.
Psychopharmacology|July 24, 1998
[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addictsR T Malison, E McCance, L L Carpenter, et al.
Neuroimage|May 22, 2009
Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry studyNeil D Woodward, David H Zald, Zhaohua Ding, et al.
Pain|February 23, 2010
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodyniaLinda S Sorkin, Mario Otto, William M Baldwin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2000
Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humansA Varrone, M Fujita, N P Verhoeff, et al.
BMC Genomics|October 7, 2014
High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual taggingPhilip K Ehrenberg, Aviva Geretz, Karen M Baldwin, et al.
Medicine and Science in Sports and Exercise|August 28, 2014
Concurrent exercise on a gravity-independent device during simulated microgravityJoshua A Cotter, Alvin Yu, Fadia Haddad, et al.
Pageof 97

Showing results (721-730 of 961) with videos related to

Sort By:
Pageof 97
Bioconjugate Chemistry|January 17, 2002
Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporterRichard R Cesati, Gilles Tamagnan, Ronald M Baldwin, et al.
Transplantation|July 31, 2001
Coagulation markers predicting cardiac transplant rejectionJ B Segal, E K Kasper, C Rohde, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administrationAkira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Transplantation|March 27, 1997
Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenograftsS K Pruitt, R R Bollinger, B H Collins, et al.
Psychopharmacology|July 24, 1998
[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addictsR T Malison, E McCance, L L Carpenter, et al.
Neuroimage|May 22, 2009
Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry studyNeil D Woodward, David H Zald, Zhaohua Ding, et al.
Pain|February 23, 2010
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodyniaLinda S Sorkin, Mario Otto, William M Baldwin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2000
Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humansA Varrone, M Fujita, N P Verhoeff, et al.
BMC Genomics|October 7, 2014
High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual taggingPhilip K Ehrenberg, Aviva Geretz, Karen M Baldwin, et al.
Medicine and Science in Sports and Exercise|August 28, 2014
Concurrent exercise on a gravity-independent device during simulated microgravityJoshua A Cotter, Alvin Yu, Fadia Haddad, et al.
Pageof 97